Burrill & Company
Signal active
Investment Firm
Overview
Burrill & Company is a venture capital and private equity firm that invests in life sciences, biotechnology, and healthcare companies.
Highlights
Founded
1994
Industry
Venture Capital
Employees
11-50
Investment
94
Lead Investment
18
Exits
27
Stages
Early Stage Venture, Late Stage Venture, Seed, Private Equity
Investor Type
Private Equity Firm
Location
United States, North America
Contact Information
Social
Profile Resume
Burrill & Company, established in 1994 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Biotechnology, Pharmaceutical, Medical, Venture Capital, Financial Services, Angel Investment, Finance, Medical Device, Health Care, Energy. The organization boasts a portfolio of 94 investments, with an average round size of $19.4M and 27 successful exits. Their recent investments include Aerovance, NGN Capital, Lehman Holdings, Apax Partners, Alta Partners. The highest investment round they participated in was $158.6B. Among their most notable exits are Aerovance and NGN Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Burrill & Company has made 94 investments. Their most recent investment was on Feb 19, 2015, when Neos Therapeutics raised $20.6M.
Burrill & Company has made 18 diversity investments. Their most recent diversity investment was on Apr 01, 2013, when Catalyst Biosciences raised $5.1M.
investments
94
Diversity investments
18
Lead investments
18
Number of exits
27
Investments
94
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Oct 22, 2013 | BetterDoctor | Internet | 2.6M |
| Mar 04, 2014 | Neos Therapeutics | Biotechnology | 15.5M |
| Apr 17, 2014 | Nora Therapeutics | Biotechnology | 18.0M |
| Feb 19, 2015 | Neos Therapeutics | Biotechnology | 20.6M |
BetterDoctor
Neos Therapeutics
Nora TherapeuticsExits
27
Funding Timeline
Funding rounds
94
Investors
0
Funds
5
Funding Rounds
94
Burrill & Company has raised 94 rounds. Their latest funding was raised on Feb 19, 2015 from a Venture Round - Neos Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Oct 22, 2013 | Seed Round - BetterDoctor | - | 2.6M | - |
| Mar 04, 2014 | Series C - Neos Therapeutics | - | 15.5M | - |
| Apr 17, 2014 | Series B - Nora Therapeutics | - | 18.0M | - |
| Feb 19, 2015 | Venture Round - Neos Therapeutics | - | 20.6M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.